Constellation Brands
STZ
118.39
+2.72
+2.35%
Constellation Brands
US · STZ
#949 by market cap
Listed 1970
118.39
+2.72
+2.35%
Live - 5344 symbols - heartbeat 149s ago
· 2026-10-08 08:38
Pre-market
117.50
-0.75%
After-hours
117.60
-0.67%
Overnight
117.21
-1.00%
- Market cap
- 20.03B
- P/E (TTM)i
- 10.60
- P/Bi
- 2.33
- EPSi
- 9.61
- Div yieldi
- 3.46%
- 52W posi
- 14%
Reader sentiment
Are you bullish or bearish on STZ?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Fair
- Altman Z-Score is 2.62, in the 1.8-3.0 "grey zone".
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year -10.48% YoY
Margins
- Gross margin
- 51.55%
- Operating margin
- 31.33%
- Net margin
- 18.46%
Key ratios & quality
- Enterprise valuei
- 30.60B
- Altman Z-Scorei
- 2.62
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 8.12B | 8.34B | 8.61B | 8.82B | 9.45B | 9.96B | 10.21B | 9.14B |
| Gross profit | 4.08B | 4.15B | 4.47B | 4.71B | 4.77B | 5.02B | 5.31B | 4.71B |
| Selling & admin expenses | 1.67B | 1.62B | 1.67B | 1.71B | 1.93B | 1.83B | 1.95B | 1.85B |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 2.41B | 2.53B | 2.79B | 3.00B | 2.84B | 3.18B | 3.36B | 2.86B |
| Pretax profit | 4.15B | -945.20M | 2.54B | 310.40M | 383.60M | 2.22B | -82.80M | 2.38B |
| Tax | 685.90M | -966.60M | 511.10M | 309.40M | 422.10M | 456.60M | -51.70M | 621.00M |
| Net profit | 3.46B | 21.40M | 2.03B | 1.00M | -38.50M | 1.77B | -31.10M | 1.76B |
| Basic EPS | 18 | 0 | 10 | 0 | 0 | 9 | 0 | 10 |
| Diluted EPS | 17.57 | -0.07 | 10.23 | -0.22 | -0.11 | 9.39 | -0.45 | 9.61 |
| Line item | 2025-02 | 2025-05 | 2025-08 | 2025-11 | 2026-02 | 2026-05 |
|---|---|---|---|---|---|---|
| Revenue | 2.16B | 2.52B | 2.48B | 2.22B | 1.92B | 2.43B |
| Gross profit | 1.11B | 1.27B | 1.31B | 1.18B | 951.70M | 1.32B |
| Selling & admin expenses | 505.30M | 500.70M | 436.00M | 491.20M | 420.50M | 457.00M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 609.40M | 765.90M | 874.00M | 692.00M | 531.20M | 863.60M |
| Pretax profit | -342.60M | 611.40M | 782.90M | 632.30M | 351.20M | 760.00M |
| Tax | 28.00M | 87.60M | 296.80M | 110.10M | 126.50M | 88.10M |
| Net profit | -370.60M | 523.80M | 486.10M | 522.20M | 224.70M | 671.90M |
| Basic EPS | -2 | 3 | 3 | 3 | 1 | 4 |
| Diluted EPS | -2.09 | 2.90 | 2.65 | 2.88 | 1.16 | 3.79 |
Balance sheet
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 3.68B | 3.48B | 3.04B | 3.33B | 3.50B | 3.73B | 3.72B | 2.91B |
| Cash & ST investments | 93.60M | 81.40M | 460.60M | 199.40M | 133.50M | 152.40M | 68.10M | 102.40M |
| Inventory | 2.13B | 1.37B | 1.29B | 1.57B | 1.90B | 2.08B | 1.44B | 1.43B |
| Total assets | 29.23B | 27.32B | 27.10B | 25.86B | 24.66B | 25.69B | 21.65B | 21.90B |
| Total current liabilities | 3.16B | 2.31B | 1.27B | 2.70B | 2.97B | 3.14B | 4.04B | 2.69B |
| Short-term debt | 1.86B | 1.05B | 98.00M | 1.01B | 1.26B | 1.29B | 2.29B | 977.50M |
| Long-term debt | 11.76B | 11.21B | 10.41B | 9.49B | 11.29B | 10.68B | 9.29B | 9.69B |
| Total liabilities | 16,394,300,000.00 | 14,848,900,000.00 | 13,175,700,000.00 | 13,808,000,000.00 | 15,928,400,000.00 | 15,627,100,000.00 | 14,517,500,000.00 | 13,513,600,000.00 |
| Total equity | 12.84B | 12.47B | 13.93B | 12.05B | 8.73B | 10.06B | 7.13B | 8.39B |
| Retained earnings | 14.28B | 13.70B | 15.12B | 14.51B | 12.34B | 13.42B | 12.60B | 13.57B |
| Line item | 2025-02 | 2025-05 | 2025-08 | 2025-11 | 2026-02 | 2026-05 |
|---|---|---|---|---|---|---|
| Total current assets | 3.72B | 3.94B | 2.88B | 2.91B | 2.91B | 3.04B |
| Cash & ST investments | 68.10M | 73.90M | 72.00M | 152.40M | 102.40M | 96.60M |
| Inventory | 1.44B | 1.41B | 1.44B | 1.38B | 1.43B | 1.45B |
| Total assets | 21.65B | 22.26B | 21.42B | 21.68B | 21.90B | 22.11B |
| Total current liabilities | 4.04B | 3.69B | 2.66B | 2.17B | 2.69B | 3.33B |
| Short-term debt | 2.29B | 1.78B | 756.60M | 378.70M | 977.50M | 1.44B |
| Long-term debt | 9.29B | 9.79B | 9.79B | 10.29B | 9.69B | 9.09B |
| Total liabilities | 14,517,500,000.00 | 14,730,600,000.00 | 13,633,100,000.00 | 13,683,100,000.00 | 13,513,600,000.00 | 13,558,900,000.00 |
| Total equity | 7.13B | 7.53B | 7.79B | 8.00B | 8.39B | 8.55B |
| Retained earnings | 12.60B | 12.94B | 13.23B | 13.55B | 13.57B | 14.05B |
Cash flow
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 2.25B | 2.55B | 2.81B | 2.71B | 2.76B | 2.78B | 3.15B | 2.67B |
| Depreciation & amortization | 333.10M | 326.50M | 293.80M | 337.30M | 383.80M | 427.90M | 445.70M | 418.70M |
| Free cash flow | 1.36B | 1.82B | 1.94B | 1.68B | 1.72B | 1.51B | 1.94B | 1.79B |
| Dividends paid | -557.70M | -569.20M | -575.00M | -573.00M | -587.70M | -653.80M | -731.80M | -715.70M |
| Stock buybacks / issuance | -504.30M | -50.00M | 0 | -1.39B | -3.20B | -249.70M | -1.12B | -924.10M |
| Ending cash balance | 93.60M | 81.40M | 460.60M | 199.40M | 133.50M | 152.40M | 68.10M | 102.40M |
| Line item | 2025-02 | 2025-05 | 2025-08 | 2025-11 | 2026-02 | 2026-05 |
|---|---|---|---|---|---|---|
| Operating cash flow | 594.70M | 637.20M | 852.10M | 616.90M | 562.80M | 661.80M |
| Depreciation & amortization | 105.90M | 105.20M | 102.70M | 99.00M | 111.80M | 97.60M |
| Free cash flow | 312.10M | 444.40M | 634.80M | 370.90M | 343.90M | 484.60M |
| Dividends paid | -180.50M | -182.20M | -178.90M | -177.70M | -176.90M | -178.70M |
| Stock buybacks / issuance | -455.70M | -306.10M | -297.90M | -220.10M | -100.00M | -223.80M |
| Ending cash balance | 68.10M | 73.90M | 72.00M | 152.40M | 102.40M | 96.60M |
Returns & efficiency
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 33.36 | -0.10 | 15.53 | -0.32 | -0.70 | 19.03 | -0.98 | 22.54 |
| ROA %i | 13.81 | -0.04 | 7.34 | -0.15 | -0.28 | 6.86 | -0.34 | 7.75 |
| ROIC %i | 16.86 | 1.18 | 9.33 | 1.02 | 1.11 | 9.49 | 1.18 | 10.17 |
| 5-year avg ROE %i | 23.98 | 20.84 | 20.53 | 15.92 | 9.58 | 6.69 | 6.51 | 7.91 |
| EBIT margin %i | 55.60 | -6.19 | 33.99 | 7.56 | 8.28 | 26.67 | 3.22 | 29.97 |
| FCF / sales %i | 16.76 | 21.87 | 22.54 | 19.03 | 18.21 | 15.17 | 18.98 | 19.63 |
| Current ratioi | 1.16 | 1.51 | 2.40 | 1.23 | 1.18 | 1.19 | 0.92 | 1.08 |
| Quick ratioi | 0.43 | 0.56 | 1.22 | 0.49 | 0.41 | 0.39 | 0.26 | 0.39 |
| Debt / assetsi | 46.58 | 46.64 | 40.52 | 42.37 | 52.55 | 48.88 | 55.95 | 51.15 |
| LT debt / equityi | 93.70 | 96.39 | 80.04 | 84.77 | 139.11 | 115.67 | 142.81 | 126.51 |
| Interest coveragei | 12.29 | -1.20 | 7.59 | 1.87 | 1.96 | 6.10 | 0.80 | 7.58 |
| Revenue CAGR (3Y) %i | 7.42 | 4.45 | 4.36 | 2.81 | 4.25 | 4.96 | 4.99 | -1.12 |
| Net income CAGR (3Y) %i | 48.23 | -- | -4.63 | -- | -- | -4.74 | -- | -- |
| FCF CAGR (3Y) %i | 37.57 | 32.26 | 30.50 | 7.27 | -1.92 | -8.03 | 4.91 | 1.38 |
| Line item | 2025-02 | 2025-05 | 2025-08 | 2025-11 | 2026-02 | 2026-05 |
|---|---|---|---|---|---|---|
| ROE %i | -0.98 | -5.05 | 15.91 | 14.29 | 22.54 | 23.51 |
| ROA %i | -0.34 | -1.83 | 5.50 | 4.99 | 7.75 | 8.22 |
| ROIC %i | 1.18 | -0.59 | 7.93 | 7.12 | 10.17 | 11.05 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 3.22 | 0.15 | 21.98 | 21.88 | 29.97 | 31.75 |
| FCF / sales %i | 18.98 | 20.55 | 19.20 | 18.78 | 19.63 | 20.25 |
| Current ratioi | 0.92 | 1.07 | 1.08 | 1.34 | 1.08 | 0.91 |
| Quick ratioi | 0.26 | 0.24 | 0.38 | 0.40 | 0.39 | 0.25 |
| Debt / assetsi | 55.95 | 51.96 | 49.23 | 49.18 | 51.15 | 47.65 |
| LT debt / equityi | 142.81 | 134.70 | 130.50 | 133.39 | 126.51 | 110.17 |
| Interest coveragei | 0.80 | 0.04 | 5.42 | 5.56 | 7.58 | 8.25 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Beer is the largest reported line at 93.87% of revenue, across 2 reported segments.
- The next-largest line, Wine and Spirits, is a distant second at 6.13% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Beer93.87%
Wine and Spirits6.13%
Quote time 2026-10-08 08:38:07 · For reference only, not investment advice and not tailored to your situation.